This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

BCBS accuses Michigan anesthesiology group of illegally keeping prices high

( April 30, 2021, 22:31 GMT | Official Statement) -- MLex Summary: Blue Cross Blue Shield has filed counterclaims accusing Anesthesia Associates of Ann Arbor (A4) of maintaining an illegal monopoly through non-compete and no-poach agreements, resulting in inflated anesthesiology prices in Michigan. “On multiple occasions, A4 has demanded higher prices for anesthesiology services with the threat to disrupt the supply of anesthesiology services to BCBSM-insured patients if BCBSM did not comply,” it argued. A4 filed an antitrust case against BCBS, accusing it of using its monopoly power to impose artificially low rates.See document below. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections